Trial Profile
Drug-drug Interaction Study to Evaluate the Pharmacokinetics and Safety of FYU-981 and Oxaprozin in Healthy Male Adults Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Sep 2022
Price :
$35
*
At a glance
- Drugs Dotinurad (Primary) ; Oxaprozin (Primary)
- Indications Hyperuricaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Mochida Pharmaceutical
- 11 Dec 2017 Status changed from not yet recruiting to completed.
- 24 Nov 2017 New trial record